StockData
Biogen Inc. logo

Biogen Inc. (BIIB) stock

BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3056% above fair value
$250.79−0.86 (-0.34%)

Close on Nov 17, 2026Market cap $37.07BP/E 107.2Yield –

Biogen profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Biogen's profit margin for the twelve months ending Sep 30, 2026 was 3.4%. For fiscal 2025 it was 13.1%, against 16.9% the year before. The highest annual figure on record is 41.0% in fiscal 2019.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202513.1%−3.8
FY2024Dec 31, 202416.9%+5.1
FY2023Dec 31, 202311.8%−18.1
FY2022Dec 31, 202229.9%+15.8
FY2021Dec 31, 202114.2%−15.6
FY2020Dec 31, 202029.8%−11.2
FY2019Dec 31, 201941.0%+8.0
FY2018Dec 31, 201832.9%+12.2
FY2017Dec 31, 201720.7%−11.7
FY2016Dec 31, 201632.3%−0.6
FY2015Dec 31, 201533.0%+2.7
FY2014Dec 31, 201430.2%+3.4
FY2013Dec 31, 201326.9%+1.8
FY2012Dec 31, 201225.0%+0.6
FY2011Dec 31, 201124.5%+3.1
FY2010Dec 31, 201021.3%−0.8
FY2009Dec 31, 200922.2%+3.0
FY2008Dec 31, 200819.1%−1.0
FY2007Dec 31, 200720.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-0.7%−19.1
Q2 FY2026Jun 30, 20263.6%−20.4
Q1 FY2026Mar 31, 202612.9%+3.0
Q4 FY2025Dec 31, 2025-2.1%−13.0
Q3 FY2025Sep 30, 202518.4%+2.6
Q2 FY2025Jun 30, 202524.0%+0.3
Q1 FY2025Mar 31, 20259.9%−7.3
Q4 FY2024Dec 31, 202410.9%+0.4
Q3 FY2024Sep 30, 202415.8%+18.4
Q2 FY2024Jun 30, 202423.7%−0.4
Q1 FY2024Mar 31, 202417.2%+1.4
Q4 FY2023Dec 31, 202310.5%−11.2
Q3 FY2023Sep 30, 2023-2.7%−47.9
Q2 FY2023Jun 30, 202324.1%−16.8
Q1 FY2023Mar 31, 202315.7%+3.7
Q4 FY2022Dec 31, 202221.6%+8.2
Q3 FY2022Sep 30, 202245.2%+33.4
Q2 FY2022Jun 30, 202240.9%+24.7
Q1 FY2022Mar 31, 202212.0%−3.2
Q4 FY2021Dec 31, 202113.5%+0.9
Q3 FY2021Sep 30, 202111.8%−8.9
Q2 FY2021Jun 30, 202116.2%−25.7
Q1 FY2021Mar 31, 202115.2%−24.4
Q4 FY2020Dec 31, 202012.5%−26.7
Q3 FY2020Sep 30, 202020.8%−22.2
Q2 FY2020Jun 30, 202041.9%+0.6
Q1 FY2020Mar 31, 202039.6%−0.8
Q4 FY2019Dec 31, 201939.2%+12.4
Q3 FY2019Sep 30, 201942.9%+0.9
Q2 FY2019Jun 30, 201941.3%+15.5
Q1 FY2019Mar 31, 201940.4%+2.9
Q4 FY2018Dec 31, 201826.8%+35.8
Q3 FY2018Sep 30, 201842.0%+2.2
Q2 FY2018Jun 30, 201825.8%−2.2
Q1 FY2018Mar 31, 201837.5%+10.9
Q4 FY2017Dec 31, 2017-9.0%−31.6
Q3 FY2017Sep 30, 201739.8%–
Q2 FY2017Jun 30, 201728.0%–
Q1 FY2017Mar 31, 201726.6%–
Q4 FY2016Dec 31, 201622.6%–

More Biogen figures

See a number that looks wrong?